SEATTLE — NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay. The new study will evaluate samples from more than 1,000 patients enrolled in the Austrian Breast & Colorectal […]
SEATTLE, WA, – Adaptive Biotechnologies Corporation, a leading provider of next-generation sequencing assays for the adaptive immune system, announced today results from the first head-to-head comparison of high throughput sequencing (HTS) using immunoSEQ™ and traditional flow cytometry. The study, which was conducted in collaboration with Fred Hutchinson Cancer Research Center and the University of Washington […]
Leuven –— Cartagenia, the world leader in providing diagnostic knowledge, analytic software and database systems to genetic labs and clinicians for patient-centric high-throughput variant assessment and clinical reporting, announces that it has signed contracts with two Canadian customers, including Mississauga, Ontario-based Credit Valley Hospital. Credit Valley Hospital laboratory is one of two Ontario provincial clinical […]
INDIANAPOLIS, — HYCOR Biomedical, Inc., a leading manufacturer of diagnostic products, and Roche today announced the signing of a global distribution agreement of KOVA® urinalysis products. As part of the agreement, Roche will distribute KOVA urinalysis plastics and controls products with its urinalysis tests and platforms worldwide for the next five years. “Concurrent with our […]
WALTHAM, Mass.–Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF (Placental Growth Factor) for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk […]
SALT LAKE CITY, UT,- Idaho Technology, Inc., a privately held clinical diagnostics company dedicated to providing the world’s fastest, highest-quality instruments for pathogen identification and DNA analysis, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of five additional pathogens for its FilmArray Respiratory Panel (FilmArray RP), a user-friendly Multiplex pathogen detection system. FilmArray […]
Utrecht (the Netherlands) – On April 26th, QIAGEN granted GenDx the non-exclusive rights to distribute world-wide, both direct and via third parties, the QIAGEN LongRange PCR kit in combination with the SBTexcellerator ® reagents for high resolution HLA typing. This elevates the cooperation between QIAGEN and GenDx and shows the commitment of both companies to […]
BioDot has begun a collaboration with GE Healthcare Life Sciences to better support customers in the diagnostic manufacturing industry. The combination of diagnostic detection and manufacturing technologies from BioDot and GE Healthcare will enable both companies to provide an integrated solution for customers involved in the development of immunoassay and molecular diagnostic kits. The collaboration […]
WOBURN, Mass.,– Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced that the company has submitted its first pre- IDE (Investigational Device Exemption) information package to the U.S. Food and Drug Administration for the Company’s Avantra® Q400 BioMarker […]
SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it has signed an agreement with U.S. health insurance provider Coventry Health Care National Network to provide coverage for the Sequenom Center for Molecular Medicine’s (Sequenom CMM) MaterniT21 PLUS laboratory-developed test (LDT). The test detects certain […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
